Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma

The treatment of patients with multiple myeloma usually includes many drugs including thalidomide, lenalidomide and bortezomib. Lovastatin and other inhibitors of HMG-CoA reductase demonstrated to exhibit antineoplasmatic and proapoptotic properties in numerous in vitro studies involving myeloma cel...

Full description

Bibliographic Details
Main Authors: Hus, Marek, Grzasko, Norbert, Szostek, Marta, Pluta, Andrzej, Helbig, Grzegorz, Woszczyk, Dariusz, Adamczyk-Cioch, Maria, Jawniak, Dariusz, Legiec, Wojciech, Morawska, Marta, Kozinska, Justyna, Waciński, Piotr, Dmoszynska, Anna
Format: Online
Language:English
Published: Springer-Verlag 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168480/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168480/

Similar Items